DADC
CLLS

D.A. Davidson & Co’s Cellectis CLLS Stock Holding History

D.A. Davidson & Co’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-500
Closed -$12K – 1232
2017
Q2 		$12K Hold
500
– – ﹤0.01% 1973
2017
Q1 		$12K Hold
500
– – ﹤0.01% 1967
2016
Q4 		$8K Buy
500
+200
+67% +$3.69K ﹤0.01% 2161
2016
Q3 		$7K Hold
300
– – ﹤0.01% 2117
2016
Q2 		$7K Hold
300
– – ﹤0.01% 2040
2016
Q1 		$8K Hold
300
– – ﹤0.01% 1948
2015
Q4 		$9K Buy
+300
New +$9.1K ﹤0.01% 1910

Other funds holding CLLS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

D.A. Davidson & Co's CLLS Position: Q3 2017 in Review

D.A. Davidson & Co sold out of Cellectis (CLLS) in Q3 2017, closing a stake of 500 shares — an estimated $12K sold.

D.A. Davidson & Co first reported a position in CLLS in Q4 2015 and held it in 7 quarters. The position peaked at $12K in Q2 2017. 42 funds tracked by Wall St. Rank hold CLLS as of Q3 2017.

  • D.A. Davidson & Co reported no remaining Cellectis position as of Q3 2017 after selling out during the quarter.
  • D.A. Davidson & Co sold 500 Cellectis shares in Q3 2017, an estimated $12K.
  • D.A. Davidson & Co first reported a position in Cellectis in Q4 2015 and held it in 7 quarters.
  • D.A. Davidson & Co's Cellectis position peaked at $12K in Q2 2017.
  • 42 funds tracked by Wall St. Rank held Cellectis as of Q3 2017.

Based on D.A. Davidson & Co's 13F filing for Q3 2017, filed 8 Nov 2017.